DOCS Stock Analysis: Buy, Sell, or Hold?

DOCS - Doximity, Inc.

SERVICES-COMPUTER PROGRAMMING SERVICES
$18.97
0.96 (5.33%) β–²
5d: -26.98%
30d: -21.77%
90d: -24.18%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026 0d

Get Alerted When DOCS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: DOCS is down 27.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$40.60
Based on 4.4% avg growth
INTRINSIC VALUE TODAY
$25.21
24.8% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.2x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: DOCS is currently trading at $18.97, which is considered oversold relative to its 30-day fair value range of $21.74 to $25.71. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.7) compared to its historical average (20.2). Remarkably, the market is currently pricing in an annual earnings decline of 16.6% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, DOCS is in a strong uptrend. Immediate support is located at $17.15, while resistance sits at $26.69. The stock is showing strong short-term momentum, up 5.3% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $27.30 (+43.9%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $21.74 - $25.71
Company Quality Score 49/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 84.3%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+5.3%)
  • BULLISH: Trading 43.9% below Wall St target ($27.30)
  • WARNING: Recommendation downgraded due to -27.0% 5-day decline - wait for stabilization

Trading Range Analysis

30-Day Trading Range $21.74 - $25.71
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $17.15
Resistance Level $26.69
Current Trend Strong Uptrend
Technical data as of May 15, 2026

Fundamental Context

Forward P/E (Next Year Est.) 11.70
Wall Street Target $27.30 (+43.9%)
Revenue Growth (YoY) 5.1%
Earnings Growth (YoY) -67.7%
Profit Margin 30.4%
Valuation Discount vs History -16.6% cheaper
PE vs Historical 11.7 vs 20.2 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -16.6% (market-implied from PE analysis)
1-Year Target $17.07 (-10%)
2-Year Target $15.37 (-19%)
3-Year Target $13.83 (-27%)
3-Yr Target (if PE normalizes) (PE: 12β†’20) $23.87 (+26%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.1, Growth: 4.8%) $41.16 (+117%)
Base: (SPY PE: 11.7, Growth: 4.8%) $21.83 (+15%)
Bear: (PE: 9.9, Growth: 4.8%) $18.55 (-2%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 19.96 | Current EPS (TTM): $0.98
Bull Case $35.58 (+88%)
Analyst growth 65.4%, PE expands to 22.0
Base Case $32.35 (+71%)
Market implied 65.4%, PE stable at 20.0
Bear Case $13.30 (-30%)
Severe decline -20.0%, PE contracts to 17.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.7 to 20.2
Stabilization Target: $32.74 (+72.6%)
PE Expansion Potential: +72.6%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 15, 2026 10:42 PM ET
Data refreshes hourly during market hours. Next update: 11:42 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Siddharth Sitaram SELL 2427 shares 2026-04-10
Siddharth Sitaram SELL 2319 shares 2026-03-10
Kira Scherer Wampler SELL 2000 shares 2026-03-03

Unlock Insider Activity

See real-time buying/selling by company executives for DOCS.

Create Free Account

Already have an account? Log In

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VEEV
Veeva Systems Inc Class A
BUY
32 analysts
$264 55 HOLD
PRVA
Privia Health Group Inc
STRONG BUY
21 analysts
$32 55 HOLD
GEHC
GE HealthCare Technologi…
STRONG BUY
21 analysts
$90 58 HOLD
PHR
Phreesia Inc
STRONG BUY
15 analysts
$16 52 HOLD
EVH
Evolent Health Inc
STRONG BUY
14 analysts
$5 60 HOLD

More Analysis for DOCS

DOCS Technical Chart DOCS Price Prediction DOCS Earnings Date DOCS Investment Advisor DOCS Fair Price Analyzer DOCS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals